USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Innovations in Stem Cells, Cellular Therapies, Diabetes Therapy, Gene Therapies, Antiaging Research, Biomarkers, and Vaccines
Innovations in Stem Cells, Cellular Therapies, Diabetes Therapy, Gene Therapies, Antiaging Research, Biomarkers, and Vaccines
15-Feb-2019
Global
$950.00
Special Price $712.50 save 25 %
Description
The Life Science, Health & Wellness TechVision Opportunity Engine (TOE) comprises analytical insights across various innovations. The TOE describes disruptive technological developments across stem cell platforms, personalized medicine, use of artificial intelligence for Alzheimer’s disease, gene therapies, melanoma management, biomarkers, vaccines, liver cancer management, monoclonal antibodies, and the management of post-partum depression.
The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.
The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.
Keywords: Stem cells, personalized medicine, biomarkers, artificial intelligence, gene therapy, monoclonal antibody, melanoma, Alzheimer’s disease, liver cancer, post-partum depression
Table of Contents
Advances in Stem Cells, Cellular Therapies, Diabetes Therapy, Gene Therapies, Antiaging Research, Biomarkers, and Vaccines
- Celularity
- Celularity
- Celularity
- Rubius Therapeutics
- Rubius Therapeutics
- Rubius Therapeutics
- Magenta Therapeutics
- Magenta Therapeutics
- Magenta Therapeutics
- Semma Therapeutics
- Semma Therapeutics
- Semma Therapeutics
- Orig3n
- Orig3n
- Orig3n
- University of California San Francisco (UCSF)
- UCSF
- UCSF
- MeiraGTx
- MeiraGTx
- MeiraGTx
- Boston University School of Medicine
- Boston University School of Medicine
- Boston University School of Medicine
- Gero
- Gero
- Gero
- Epitopoietic Research Corporation
- Epitopoietic Research Corporation
- Epitopoietic Research Corporation
- Provention Bio
- Provention Bio
- Provention Bio
- Sage Therapeutics
- Sage Therapeutics
- Sage Therapeutics
- Basilea Pharmaceutica
- Basilea Pharmaceutica
- Basilea Pharmaceutica
- Exelixis
- Exelixis
- Exelixis
- NYU
- NYU
- NYU
- University of Washington
- University of Washington
- University of Washington
- Roslin Institute
- Roslin Institute
- Roslin Institute Features of chicken eggs as bioreactors
- ESCO Aster
- ESCO Aster
- ESCO Aster
- Agenus
- Agenus
- Agenus
- Indian Institute of Technology, Mandi
- Indian Institute of Technology, Mandi
- Indian Institute of Technology, Mandi
- Liverpool School of Tropical Medicine
- Liverpool School of Tropical Medicine
- Liverpool School of Tropical Medicine
- University of Chicago
- University of Chicago
- University of Chicago
- UroGen
- UroGen
- UroGen
- Unity Biotechnology
- Unity Biotechnology
- Unity Biotechnology
- Bruin Biometrics
- Bruin Biometrics
- Bruin Biometrics
- Teva Pharmaceutical Industries
- Teva Pharmaceutical Industries
- Teva Pharmaceutical Industries
- Key Contacts
- Key Contacts (continued)
- Key Contacts (continued)
- Key Contacts (continued)
- Key Contacts (continued)
- Your F&S Thought Leader
Related Research
Popular Topics
| No Index | No |
|---|---|
| Podcast | No |
| Industries | Healthcare |
| WIP Number | D759-00-05-00-00 |
| Is Prebook | No |
| Ti Codes | D759,D904,D913,D91A,D91B,D932,D933,D935,D936,D937 |